跳至主要内容
临床试验/CTIS2023-507956-56-00
CTIS2023-507956-56-00招募中1 期

ong-Term Follow-Up of Subjects Treated With NTLA-2002 - ITL-2002-CL-999

Intellia Therapeutics Inc.0 个研究点目标入组 29 人开始时间: 2023年9月25日最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
29

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 65+(—)
性别
All

入选标准

  • A subject has completed or discontinued from an Intellia-sponsored or -supported treatment protocol in which a complete or partial dose of NTLA-2002 was received., A subject has provided informed consent for the LTFU study, A subject is willing to attend study visits, complete protocol-required follow-up schedule, and comply with the study requirements.

排除标准

  • Not applicable

研究者

发起方
Intellia Therapeutics Inc.

相似试验